Collectively, these results indicate that FOXO1-stimulated G6PD expression in cancer cells can promote their antioxidative capacity, thus reducing apoptosis, increasing proliferation, and enhancing tumor growth under oxidative stress conditions. Here, G6PD is linked to neoplasm.